Share Price, page-3198

Appreciate the sentiments and you clearly have an understanding of the background and work it has taken to get NEU to this point but without meaning any disrespect I completely disagree that “FDA approval is hardly an issue here” or for that matter that significant patience is required with respect to share price.

FDA approval is a massive issue here - the most important event this company has faced to date IMO. As has been discussed here recently highly likely but by no means a certainty. With FDA approval NEU is an income generating cash cow with 4 phase 2 trials cooking away and becomes a massive takeover target before or after those phase 2 results are known. Share price given FDA approval has to be north of $12 I believe and will likely rise through 2023. Without FDA approval NEU has significant funding issues again, 4 phase 2 trials that wouldn’t look anywhere near as promising with an unproven drug 5+ years from commercialisation and a share price of (I’m guessing) approximately $1.

All of which is going to unfold in the next 40 trading days if not before. Any chance you could explain how you could possibly think otherwise??